Allogeneic sibling umbilical-cord blood transplantation in children with malignant and non-malignant disease
Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214-219.
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling
Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. New Engl J Med 1989; 321: 1174-1178.
Optimal processing of human umbilical cord blood for clinical banking
Denning-Kendall PA, Donaldson C, Nicol A et al. Optimal processing of human umbilical cord blood for clinical banking. Exp Hematol 1996; 24: 1394-1401.
Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells
Lyman SD, James L, Vanden Bos T et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1994; 75: 1157-1167.
The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative effects on human megakaryocyte progenitors
Debili N, Wendling F, Katz A et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative effects on human megakaryocyte progenitors. Blood 1995; 86: 2516-2525.
Density separation and cryopreservation of umbilical cord blood cells: Evaluation of recovery in short-term and long-term cultures
Almici C, Carlostella C, Wagner JE, Rizzoli V. Density separation and cryopreservation of umbilical cord blood cells: evaluation of recovery in short-term and long-term cultures. Acta Haematol 1996; 95: 171-175.